Okay. Thank you, Mr. Buckley.
Ms. Kramchynsky, since 2023, Vanessa's Law authorities have applied to NHPs. This gives the minister the ability to order a recall where an NHP represents a serious or imminent risk to injury or health. If Bill C-224 removes NHPs from the definition of therapeutic product, this specific authority would no longer apply to NHPs.
If Health Canada identifies an NHP that is contaminated with lead, E. coli or another dangerous substance, and the company refuses to voluntarily recall the product, what specific statutory authority would Health Canada have under Bill C-224 to compel an immediate recall?